Morsua, Jaime M.
HRN: 14-74-01 Sex: MalePatient Encounter
AMS Audit List
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
12/06/2023
CEFTAZIDIME 1GM (VIAL)
12/06/2023
12/12/2023
IV
1g
Q8
Pleural Effusion Right Prob Sec To Parapneumonic Process
Checking Final Appropriateness
01/05/2024
AMPICILLIN 1GM + SULBACTAM 500MG (VIAL)
01/05/2024
01/11/2024
IVT
1.5g
Q8
CAP MR; Pleural Effusion R
Checking Final Appropriateness
01/09/2024
AMPICILLIN 1GM + SULBACTAM 500MG (VIAL)
01/09/2024
01/15/2024
IV
1.5g
Q8
CAP-MR; Pleural Effusion
Checking Final Appropriateness